Feedback / Questions
Jivadco (trastuzumab duocarmazine) - Byondis, Medac
https://www.cancertherapyadvisor.com/home/news/conference-coverage/european-society-for-medical-oncology-esmo/esmo-2023/trastuzumab-duocarmazine-improves-pfs-her2-advanced-breast-cancer/
Oct 23, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next